Latest AusBiotech News | Page 13

Approval for Neuren Pharmaceuticals’ Phase 2 trial in Angelman syndrome
Patrys selects stable cell line for production of PAT-DX3
Lucy Turnbull AO rejoins board of Immutep
AusBiotech highlights clarity and transparency is key in recent submissions
Kazia Therapeutics to be ‘transformed’ by pipeline progress
New award recognises industry’s role in clinical trials
Arovella Therapeutics closes over-subscribed share purchase plan
Important support programme oversubscribed
Amplia says new report ‘paves way’ for its phase 2 trial
Engage early on reimbursement and regulation strategies
Vaccine developer Sementis appoints chief operating officer
New Prostheses List pathways proposed
New chair for Agricultural Biotechnology Council of Australia
Tessara Therapeutics announces key senior appointments
CSL campaign challenging stereotypes about people working in science
Senate Inquiry into sovereign manufacturing report released
AusBiotech greets patent box legislation
NeuroScientific Biopharmaceuticals reports outcomes of pre-clinical studies
Medlab Clinical updates on progress towards phase 3 trial
Applications for Bridge Programme 2022 open
Cytiva announces winner of Australia-NZ BioChallenge
Changes proposed to TGA fees and charges
New trial underway of Pharmaxis’ first-in-class LOX inhibitor
Exopharm announces new agreement with Astellas Institute for Regenerative Medicine
Certainty offered for RDTI clinical trial activities
First patient dosed in Telix ‘ProstACT’ therapeutic program
New partnership between BiomeBank and Hudson Institute
Keynote announced for NSW Women in Life Sciences Luncheon
Technovalia announces interim safety results from vaccine phase 1 trial
Significant capital raise for emerging Australian company
Global biomanufacturing report seeks Australian voice
BiomeBank appoints new chair to accelerate commercialisation strategy
Patients dosed in Dimerix’s DMX-200 Covid late-stage study in India
Pharmaxis welcomes government research grants for new study collaborations
Recharged with resolutions for 2022
AusBiotech office closure 21 December
QIMR Berghofer attracts support for potential multiple sclerosis treatment
CSL completes $6.3 billion placement to support Vifor acquisition
Uniting to progress biotech in year ahead
Australia’s health security audit closing with year
Recce Pharmaceuticals update on clinical trial of burn wound infections
Save date: NSW Women in Life Sciences Luncheon announced
Positive late-stage trial results for Neuren Pharmaceuticals’ trofinetide
Australian-produced eucalyptus compound effective at treating lung damage in sheep mode
2021 Brilliant Women in Digital Health
US FDA grants new fast designation for Bionomics’ BNC210
New discoveries make steps toward lipoedema diagnosis and treatment
Call for Australasian Biotechnology journal abstracts